US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 3.590
  • -0.020-0.55%
Close May 20 16:00 ET
  • 3.560
  • -0.030-0.84%
Post 18:53 ET
529.05MMarket Cap-2409P/E (TTM)

Adaptive Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
-10.08%-46.68M
49.95%-23.56M
8.22%-59.15M
4.56%-183.95M
44.23%-30.02M
2.38%-42.41M
-26.47%-47.07M
Net income from continuing operations
17.62%-47.53M
-12.45%-225.3M
-72.94%-69.47M
-11.05%-50.33M
8.20%-47.81M
8.12%-57.7M
3.34%-200.37M
34.53%-40.17M
19.07%-45.32M
-5.64%-52.08M
Depreciation and amortization
-3.85%5.21M
6.27%22.23M
2.01%5.39M
7.06%5.76M
8.82%5.65M
7.26%5.42M
49.93%20.92M
9.01%5.29M
52.58%5.38M
78.83%5.2M
Other non cash items
-31.52%2.37M
51.25%12.39M
1.68%2.17M
49.80%3.71M
68.83%3.05M
95.15%3.46M
17.88%8.19M
25.71%2.14M
40.16%2.48M
2.67%1.81M
Change In working capital
57.89%-10.31M
35.45%-46.18M
66.50%-3.51M
3.75%-18.65M
102.30%449K
-10.21%-24.48M
-25.93%-71.55M
13.86%-10.48M
-214.17%-19.37M
-230.72%-19.48M
-Change in receivables
-144.60%-4.05M
108.97%2.03M
49.91%-6.77M
111.78%334K
47.99%-621K
277.82%9.09M
-207.63%-22.65M
-4,606.97%-13.51M
3.80%-2.84M
-121.40%-1.19M
-Change in inventory
116.82%1.11M
-447.37%-2.84M
31.30%3.98M
-479.17%-273K
111.93%65K
-279.93%-6.61M
115.71%817K
393.51%3.03M
-81.10%72K
54.20%-545K
-Change in prepaid assets
531.82%1.52M
-154.35%-1.93M
-31.05%2.03M
-9,969.77%-4.33M
325.79%718K
-136.59%-352K
176.13%3.55M
-16.31%2.95M
98.98%-43K
-144.04%-318K
-Change in payables and accrued expense
75.18%-3.94M
-176.04%-5.41M
-49.30%5.34M
-150.71%-2.81M
662.72%7.94M
-110.44%-15.88M
80.48%7.11M
767.30%10.53M
-30.74%5.54M
-129.51%-1.41M
-Change in other working capital
53.89%-4.94M
37.00%-38.04M
39.95%-8.1M
47.66%-11.57M
52.21%-7.65M
-22.17%-10.72M
-22.02%-60.38M
-5.35%-13.48M
-200.34%-22.1M
-1.46%-16.02M
Cash from discontinued investing activities
Operating cash flow
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
-10.08%-46.68M
49.95%-23.56M
8.22%-59.15M
4.56%-183.95M
44.23%-30.02M
2.38%-42.41M
-26.47%-47.07M
Investing cash flow
Cash flow from continuing investing activities
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
-54.95%26.14M
686.41%37.32M
67.11%62.98M
-98.40%2.91M
-245.13%-97.54M
372.78%58.02M
-88.55%4.75M
Net PPE purchase and sale
48.32%-1.51M
34.57%-10.7M
48.94%-1.3M
48.86%-2.78M
30.22%-3.7M
4.97%-2.92M
73.52%-16.35M
72.50%-2.54M
62.84%-5.43M
75.96%-5.3M
Net investment purchase and sale
-30.17%46.02M
628.91%140.34M
104.74%4.51M
-54.42%28.92M
308.40%41.02M
61.67%65.9M
-92.08%19.25M
-224.26%-95M
1,054.23%63.45M
-84.18%10.04M
Cash from discontinued investing activities
Investing cash flow
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
-54.95%26.14M
686.41%37.32M
67.11%62.98M
-98.40%2.91M
-245.13%-97.54M
372.78%58.02M
-88.55%4.75M
Financing cash flow
Cash flow from continuing financing activities
-93.45%44K
-98.30%2.25M
1,350.00%87K
-99.99%17K
-63.18%1.47M
-75.55%672K
387.24%132.27M
-99.82%6K
4,189.82%125.52M
-36.95%3.99M
Proceeds from stock option exercised by employees
-93.45%44K
-71.55%2.25M
-72.98%87K
-97.95%17K
-63.18%1.47M
-75.55%672K
-70.47%7.89M
-90.18%322K
-71.67%829K
-36.95%3.99M
Net other financing activities
----
----
----
----
----
----
28,891.84%124.38M
---316K
----
----
Cash from discontinued financing activities
Financing cash flow
-93.45%44K
-98.30%2.25M
1,350.00%87K
-99.99%17K
-63.18%1.47M
-75.55%672K
387.24%132.27M
-99.82%6K
4,189.82%125.52M
-36.95%3.99M
Net cash flow
Beginning cash position
-26.43%68M
-34.54%92.43M
-58.35%91.63M
42.23%112.16M
-17.29%96.93M
-34.54%92.43M
12.45%141.2M
76.64%219.99M
-57.68%78.86M
-33.33%117.19M
Current changes in cash
37.81%6.2M
49.91%-24.43M
81.47%-23.64M
-114.55%-20.53M
139.75%15.24M
118.73%4.5M
-412.08%-48.78M
-865.46%-127.56M
328.42%141.13M
-462.90%-38.33M
End cash Position
-23.45%74.2M
-26.43%68M
-26.43%68M
-58.35%91.63M
42.23%112.16M
-17.29%96.93M
-34.54%92.43M
-34.54%92.43M
76.64%219.99M
-57.68%78.86M
Free cash flow
35.78%-39.86M
16.61%-167.02M
13.30%-28.23M
-3.39%-49.46M
47.95%-27.25M
8.08%-62.08M
21.29%-200.29M
48.37%-32.56M
17.61%-47.84M
11.63%-52.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 35.16%-38.35M15.02%-156.32M10.28%-26.93M-10.08%-46.68M49.95%-23.56M8.22%-59.15M4.56%-183.95M44.23%-30.02M2.38%-42.41M-26.47%-47.07M
Net income from continuing operations 17.62%-47.53M-12.45%-225.3M-72.94%-69.47M-11.05%-50.33M8.20%-47.81M8.12%-57.7M3.34%-200.37M34.53%-40.17M19.07%-45.32M-5.64%-52.08M
Depreciation and amortization -3.85%5.21M6.27%22.23M2.01%5.39M7.06%5.76M8.82%5.65M7.26%5.42M49.93%20.92M9.01%5.29M52.58%5.38M78.83%5.2M
Other non cash items -31.52%2.37M51.25%12.39M1.68%2.17M49.80%3.71M68.83%3.05M95.15%3.46M17.88%8.19M25.71%2.14M40.16%2.48M2.67%1.81M
Change In working capital 57.89%-10.31M35.45%-46.18M66.50%-3.51M3.75%-18.65M102.30%449K-10.21%-24.48M-25.93%-71.55M13.86%-10.48M-214.17%-19.37M-230.72%-19.48M
-Change in receivables -144.60%-4.05M108.97%2.03M49.91%-6.77M111.78%334K47.99%-621K277.82%9.09M-207.63%-22.65M-4,606.97%-13.51M3.80%-2.84M-121.40%-1.19M
-Change in inventory 116.82%1.11M-447.37%-2.84M31.30%3.98M-479.17%-273K111.93%65K-279.93%-6.61M115.71%817K393.51%3.03M-81.10%72K54.20%-545K
-Change in prepaid assets 531.82%1.52M-154.35%-1.93M-31.05%2.03M-9,969.77%-4.33M325.79%718K-136.59%-352K176.13%3.55M-16.31%2.95M98.98%-43K-144.04%-318K
-Change in payables and accrued expense 75.18%-3.94M-176.04%-5.41M-49.30%5.34M-150.71%-2.81M662.72%7.94M-110.44%-15.88M80.48%7.11M767.30%10.53M-30.74%5.54M-129.51%-1.41M
-Change in other working capital 53.89%-4.94M37.00%-38.04M39.95%-8.1M47.66%-11.57M52.21%-7.65M-22.17%-10.72M-22.02%-60.38M-5.35%-13.48M-200.34%-22.1M-1.46%-16.02M
Cash from discontinued investing activities
Operating cash flow 35.16%-38.35M15.02%-156.32M10.28%-26.93M-10.08%-46.68M49.95%-23.56M8.22%-59.15M4.56%-183.95M44.23%-30.02M2.38%-42.41M-26.47%-47.07M
Investing cash flow
Cash flow from continuing investing activities -29.33%44.51M4,362.89%129.65M103.29%3.21M-54.95%26.14M686.41%37.32M67.11%62.98M-98.40%2.91M-245.13%-97.54M372.78%58.02M-88.55%4.75M
Net PPE purchase and sale 48.32%-1.51M34.57%-10.7M48.94%-1.3M48.86%-2.78M30.22%-3.7M4.97%-2.92M73.52%-16.35M72.50%-2.54M62.84%-5.43M75.96%-5.3M
Net investment purchase and sale -30.17%46.02M628.91%140.34M104.74%4.51M-54.42%28.92M308.40%41.02M61.67%65.9M-92.08%19.25M-224.26%-95M1,054.23%63.45M-84.18%10.04M
Cash from discontinued investing activities
Investing cash flow -29.33%44.51M4,362.89%129.65M103.29%3.21M-54.95%26.14M686.41%37.32M67.11%62.98M-98.40%2.91M-245.13%-97.54M372.78%58.02M-88.55%4.75M
Financing cash flow
Cash flow from continuing financing activities -93.45%44K-98.30%2.25M1,350.00%87K-99.99%17K-63.18%1.47M-75.55%672K387.24%132.27M-99.82%6K4,189.82%125.52M-36.95%3.99M
Proceeds from stock option exercised by employees -93.45%44K-71.55%2.25M-72.98%87K-97.95%17K-63.18%1.47M-75.55%672K-70.47%7.89M-90.18%322K-71.67%829K-36.95%3.99M
Net other financing activities ------------------------28,891.84%124.38M---316K--------
Cash from discontinued financing activities
Financing cash flow -93.45%44K-98.30%2.25M1,350.00%87K-99.99%17K-63.18%1.47M-75.55%672K387.24%132.27M-99.82%6K4,189.82%125.52M-36.95%3.99M
Net cash flow
Beginning cash position -26.43%68M-34.54%92.43M-58.35%91.63M42.23%112.16M-17.29%96.93M-34.54%92.43M12.45%141.2M76.64%219.99M-57.68%78.86M-33.33%117.19M
Current changes in cash 37.81%6.2M49.91%-24.43M81.47%-23.64M-114.55%-20.53M139.75%15.24M118.73%4.5M-412.08%-48.78M-865.46%-127.56M328.42%141.13M-462.90%-38.33M
End cash Position -23.45%74.2M-26.43%68M-26.43%68M-58.35%91.63M42.23%112.16M-17.29%96.93M-34.54%92.43M-34.54%92.43M76.64%219.99M-57.68%78.86M
Free cash flow 35.78%-39.86M16.61%-167.02M13.30%-28.23M-3.39%-49.46M47.95%-27.25M8.08%-62.08M21.29%-200.29M48.37%-32.56M17.61%-47.84M11.63%-52.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg